GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Credit Rating
Glenmark Pharmaceuticals Outlook Revised to Positive on proposed GLS Stake Sale; ''BB'' Rating Affirmed28-09-2023
28-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi in Europe and South Africa27-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Credit Rating
India Ratings has discontinued and withdrawn the outstanding voluntary issuer ratings disclosure due to regulatory requirements.23-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Details of Analyst/ Investors Meeting is attached22-09-2023
Glenmark Pharma to sell 75% in GLS to Nirma Ltd for 5,651 crore
The transaction will help strengthen Glenmark Pharma's balance sheet21-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Clarification On News Article
Clarification on News Article21-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation - Glenmark Pharma announces proposed divestment of Majority Stake in Glenmark Life Sciences Limited21-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Glenmark Pharma announces proposed Divestment of Majority Stake in Glenmark Life Sciences Limited21-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Board Meeting Outcome for Outcome Of The Board Meeting Held On September 21, 2023
Disclosure under Regulation 30 of SEBI (LODR) Regulations, 201521-09-2023
GLENMARK PHARMACEUTICALS LTD. - 532296 - Clarification sought from Glenmark Pharmaceuticals Ltd
The Exchange has sought clarification from Glenmark Pharmaceuticals Ltd on September 21, 2023, with reference to news appeared inwww.moneycontrol.com dated September 21, 2023 quoting "Glenmark Life Sciences gains on parent Glenmark Pharma plan to pare stake"The reply is awaited.21-09-2023